In addition, in line with the present study results, we examined P53 and its mechanism in prostate cancer and observed that prostate cancer cells have low P53 expression (p > 0.05), leading to an increase in the migration and adhesion of PC cells by inhibiting JNK and ERK activation. This evidence concerns the gene TP53 and prostate carcinoma.